EASL – International Liver Congress 2021
23–26 June 2021
Digital congress
鶹ƽ will be present from the 23th to the 26th of June 2021 at the digital EASL International Liver Congress with a first poster “A phase 2 study testing FXR agonist Vonafexor in treatment naive patients with chronic hepatitis B (CHB): preliminary week 16 results” (EASL-ICL 2021 Abstract No. 2844) in the Hepatitis B/D Therapy Session:
And a second poster “Farnesoid X receptor alpha ligands inhibit in vitro HDV replication and virion secretion and infectivity”